Alanyl tRNA synthetase fragment - aTyr Pharma
Alternative Names: AARS; AARS-1Latest Information Update: 14 Feb 2023
At a glance
- Originator aTyr Pharma
- Class Antifibrotics; Peptide fragments
- Mechanism of Action Type 4 fibroblast growth factor receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Fibrosis